Table 3.
A prostanoid E receptor antagonist protected against synapse degeneration
Synaptophysin (units) | |||
---|---|---|---|
Treatment | Vehicle control | Prostanoid E receptor antagonist AH13205 | Prostanoid D receptor antagonist BWA868C |
Vehicle control | 100 ± 6 | 99 ± 7 | 99 ± 3 |
200 nM PrP82-146 | 22 ± 5 | 87 ± 8 | 30 ± 7 |
100 nM Aβ1-42 | 32 ± 6 | 93 ± 5 | 34 ± 6 |
1 μM PLAP | 27 ± 7 | 91 ± 7 | 38 ± 6 |
10 nM PAF | 31 ± 4 | 85 ± 9 | 32 ± 5 |
10 nM Prostaglandin E2 | 30 ± 5 | 97 ± 3 | 33 ± 6 |
Primary cortical neurones were pre-treated with a vehicle control, a prostanoid E receptor antagonist (100 nM AH13205) or a prostanoid D receptor antagonist (100 nM BWA868C) for 1 hour prior to incubation with PrP82-146, Aβ1-42, PLAP, PAF or prostaglandin E2 as shown for 24 hours. Values shown are the mean average amount of synaptophysin ± SD, n = 9.